Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct size

International Journal of Cardiology

Volumn 59, Issue 1, 1997, Pages 21-27

  Herzog, William R ^a   Vogel, Robert A ^a   Schlossberg, Matthew L ^a   Edenbaum, Lisa R ^a   Scott, Helen J ^a   Serebruany, Victor L ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Animal model; Calcium channel blockers; Diltiazem; Myocardial infarction; Reperfusion injury

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

EID: 0030936531     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02883-5     Document Type: Article

References (26)

1. Yusuf S. An overview of the clinical trials of agents (other than β-blockers) that potentially limit myocardial infarct size. J Cardiovasc Pharm 1988;12 (suppl. 1): S48-55.
2. Roberts R. Review of calcium antagonists trials in acute myocardial infarction. Clin Cardiol 1989; 12 (suppl III):III-4-47.
3. Gibson RS, Boden WE, Theroux P. Diltiazem and reinfarction in patients with non Q-wave myocardial infarction: results of a double-blind, randomized, multicenter trial. New Engl J Med 1985; 315: 423-429.
4. Stone PH, Muller JE. Nifedipine therapy for recurrent ischemic pain following myocardial infarction. Clin Cardiol 1982; 5: 223-230.
5. Bush LR, Romson JL, Ash JL, Lucchesi BR. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J Cardiovasc Pharm 1982; 4: 285-296.
6. Kloner RA, Braunwald E. Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 1987; 59: 84B-94B.
7. Fujiwara H, Ashraf M, Millard RW, Sato S, Schwartz A. Effects of diltiazem, a calcium channel inhibitor, in retarding cellular damage produced during early myocardial ischemia in pigs: a morphometric and ultrastructural analysis. J Am Coll Cardiol 1984; 3: 1427-1437.
8. Kloner RA, Przyklenk K. Experimental infarct size reduction with calcium channel blockers. J Am Coll Cardiol 1991; 18: 876-878.
9. Higginson L, Tang A, Knoll G, Calvin J. Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart. J Am Coll Cardiol 1991; 18: 868-875.
10. Lo HM, KIoner RA, Braunwald E. Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. Am J Cardiol 1985; 56: 672-677.
11. Fedor JL, McIntosh DM, Rembert JC, Greenfield JC. Coronary and transmural myocardial blood flow responses in awake domestic pigs. Am J Physiol 1978; 235: H435-444.
12. Dodds WJ. The pig model for biomedical research. Fed Proc 1982; 41: 247-256.
13. Yao SK, Ober JC, Gonenne A, Clubb FJ Jr, Krishnaswami A, Ferguson JJ, Anderson HV, Gorecki M, Buja LM, Willerson JT. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res 1993: 73: 952-967.
14. Jam D, Crawley JC, Lahiri A, Raftery EB. Indium - III antimyosin images compared with triphenyl tetrasolium chloride staining in a patient 6 days after myocardial infarction. J Nucl Med 1990; 31: 231-233.
15. Skolnick AE, Frishman WH. Calcium channel blockers in myocardial infarction. Arch Intern Med 1989; 149: 1669-1677.
16. Deleheye F, de Gevigney G, Ovize M, Landrivon G, Rabilloud M, Andre- Fouet X, Delaye J. Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists. Arch Malad Cocur Vaiss 1992; 85: 1717-1724.
17. Marban E. Myocardial stunning and hibernating. The physiology behind the colloquialism. Circulation 1991; 83: 681-688.
18. Flaim SF, Zelis R. Diltiazem pretreatment reduces experimental infarct size in rat. Pharmacology 1981; 23: 281-286.
19. Klein HH, Schubothe M, Nebendahl K. The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts. Circulation 1984; 69: 1000-1005.
20. Zamanis A, Verdetti J, deLeiris J. Reduction of ischemia-induced myocardial necrosis in the rat with permanent coronary artery occlusion under the effect of diltiazem. J Moll Cell Cardiol 1982; 14: 53-62.
21. Garcia-Dorado D, Theroux P, Fernandex-Aviles F, Elizaga J, Solares J, Galinanes M. Diltiazem and progression of myocardial ischemic damage during coronary artery occlusion and reperfusion in porcine hearts. J Am Coll Cardiol 1987; 10: 906-911.
22. Ruffolo RR, Bril A, Feuerstein GZ. Cardioprotective potential of carvedilol. Cardiology 1993; 82 (Suppl.3): 24-28.
23. Klein HH, Pich S, Lindert S, Nebendahl K, Warneke G, Kreuzer H. Treatment of reperfusion injury with intracoronary calcium channel antagonists and reduced coronary free calcium concentration in regionally ischemic, reperfused porcine hearts. J Am Coll Cardiol 1989; 13: 1395-1401.
24. Rousseau G, St-Jean G, Latour J-G, Merhi Y, Nattel S, Waters D. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium. Cardiovasc Res 1991; 25: 319-329.
25. Goldstein RE, Boccuzzi ST, Cruess D, Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991; 83: 52-60.
26. Packer M. Calcium channel blockers in chronic heart failure: the risks of 'physiologically rational' therapy. Circulation 1990; 82: 2254-2257.